Evidence map›Paper›PMID 19262465›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2009

Risk markers for depression in adolescents: sleep and HPA measures.

Uma Rao, Constance L Hammen, Russell E Poland

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 4 pooled it
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 4 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. The use ofFrontiers in cell and developmental biology · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Molecular Biomarkers for Pediatric Depressive Disorders: A Narrative Review.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Uma RaoDepartment of Psychiatry, the University of Texas Southwestern Medical Center, Dallas, TX 75390-9101, USA. uma.rao@utsouthwestern.edu
Constance L Hammen
Russell E Poland
Southwestern Medical Center · USTexas Health Resources Foundation · USUniversity of California, Los Angeles · US

Funding

Risk for Substance Abuse in Depressed AdolescentsR01MH062464 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2001 to 2006
$2.4M
Stress Response and Smoking Cessation in Depressed YouthR01DA015131 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2003 to 2007
$2.4M
Markers of Risk for Nicotine Dependence in YoungstersR01DA014037 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2001 to 2006
$1.9M
Treatment Prediction in Adolescent and Adult DepressionR01MH068391 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2004 to 2012
$1.7M
Stress and Risk for Substance Abuse in AdolescentsR01DA017804 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2004 to 2008
$1.6M
Neuronal Risk Markers for Nicotine Dependence in YouthR01DA017805 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2004 to 2010
$1.4M
PATHWAYS TO JUVENILE DEPRESSION--BIOPSYCHOSOCIAL MODELSK08MH001419 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAO, UMA · 1996 to 2000
$150k
NIDA NIH HHS DA14037NIDA NIH HHS DA15131NIDA NIH HHS DA17804NIDA NIH HHS DA17805NIDA NIH HHS R01 DA014037NIDA NIH HHS R01 DA015131NIDA NIH HHS R01 DA017804NIDA NIH HHS R01 DA017805NIMH NIH HHS K08 MH001419NIMH NIH HHS MH01419NIMH NIH HHS MH62464NIMH NIH HHS MH68391NIMH NIH HHS R01 MH062464NIMH NIH HHS R01 MH068391
6 · The paper itself

Abstract

Previous work has demonstrated reliable electroencephalographic (EEG) sleep and hypothalamic-pituitary-adrenal (HPA) changes associated with adult major depressive disorder. These changes might be evident before clinical manifestation of the illness in at-risk persons. The aim of the study was to identify depression-related EEG sleep and HPA changes in healthy adolescents at high risk for depression, and to examine the relationship between EEG sleep (or HPA) changes and the onset of depression. Forty-eight adolescent volunteers with no personal history of a psychiatric illness, including depression, but who were at high risk for developing depression by virtue of parental depression (high-risk group), and 48 adolescent volunteers with no personal or family history of a psychiatric disorder (normal controls) were recruited. EEG sleep and HPA measures were collected on three consecutive evenings and nights at baseline. Clinical follow-up evaluations were conducted at regular intervals over a 5-year period. Compared with normal controls, adolescents at high risk for depression had shorter latency to rapid eye movement (REM) sleep, increased phasic REM sleep, more REM sleep and elevated nocturnal urinary-free cortisol (NUFC) excretion at baseline. Shorter REM latency, higher REM density and elevated NUFC (measured at baseline) were associated with the development of depression during follow-up. The findings that REM sleep abnormalities and elevated HPA activity occur before the onset of depression in at-risk adolescents suggest that these variables serve as vulnerability markers for the illness.

Indexed as

AdolescentBiomarkersCausalityComorbidityDepressive DisorderElectroencephalographyFemaleHumansHydrocortisoneHypothalamic DiseasesHypothalamo-Hypophyseal SystemMaleRisk FactorsSleep, REMSleep Wake DisordersBiomarkersHydrocortisone

Identifiers

PMID19262465
PMCPMC2697268
OpenAlexW2058978561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.